168 related articles for article (PubMed ID: 8010874)
1. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
Sarna S; Bhola RK
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
[TBL] [Abstract][Full Text] [Related]
2. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
Prasad SB; Giri A; Arjun J
Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide and ascorbic acid-mediated ultrastructural and biochemical changes in Dalton's lymphoma cells in vivo.
Prasad SB; Rosangkima G; Nicol BM
Eur J Pharmacol; 2010 Oct; 645(1-3):47-54. PubMed ID: 20655303
[TBL] [Abstract][Full Text] [Related]
4. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
5. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
7. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
Gupta V; Singh SM
Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro.
Nagy B; Mucsi I; Molnár J; Thurzo L
Anticancer Res; 2002; 22(1A):135-8. PubMed ID: 12017276
[TBL] [Abstract][Full Text] [Related]
9. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
10. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin- and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice.
Martha KR; Rosangkima G; Amenla L; Rongpi T; Prasad SB
Fundam Clin Pharmacol; 2013 Jun; 27(3):329-38. PubMed ID: 22211279
[TBL] [Abstract][Full Text] [Related]
12. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
Singh V; Singh SM
Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
[TBL] [Abstract][Full Text] [Related]
13. Chlorambucil and ascorbic acid-mediated anticancer activity and hematological toxicity in Dalton's ascites lymphoma-bearing mice.
Kalita S; Verma AK; Prasad SB
Indian J Exp Biol; 2014 Feb; 52(2):112-24. PubMed ID: 24597143
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate.
Lee K; Erturk E; Mayer R; Cockett AT
Cancer Res; 1987 Oct; 47(19):5021-4. PubMed ID: 2441860
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
Schiller JH; Bittner G
Clin Cancer Res; 1999 Dec; 5(12):4287-94. PubMed ID: 10632372
[TBL] [Abstract][Full Text] [Related]
16. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
18. Application of high energy shock waves to cancer treatment in combination with cisplatin and ATX-70.
Maruyama M; Asano T; Nakagohri T; Uematsu T; Hasegawa M; Miyauchi H; Iwashita C; Isono K
Anticancer Res; 1999; 19(3A):1989-93. PubMed ID: 10470144
[TBL] [Abstract][Full Text] [Related]
19. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
[TBL] [Abstract][Full Text] [Related]
20. Chemoimmunotherapeutical studies on Dalton's lymphoma with cis-platin.
Bahadur A
Pol J Pharmacol Pharm; 1985; 37(4):463-8. PubMed ID: 4080643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
